skip to main content

Publications

Recent Publications

  • Khuroo, T, E M. Mohamed, Sathish Dharani, S Immadi, Mohammad T. Nutan, Dai Lu, Hamed Alyismail, Mansoor A. Khan, and Ziyaur Rahman. 2022. “In-Situ Implant Formulation of Laurate and Myristate Prodrugs of Dolutegravir for Ultra-Long Delivery.” Journal of Pharmaceutical Sciences111 (August): 2312–21.
  • Ahmed, Eman Y., Omaima M. Abdelhafez, Dalia Zaafar, Aya M. Serry, Yasmine H. Ahmed, Rania Farag A El-Telbany, Abd Elmageed, Zakaria Y, Hamed I. Ali, and Hamed Alyismail. 2022. “Antitumor and Multikinase Inhibition Activities of Some Synthesized Coumarin and Benzofuran Derivatives.” Arch Pharm (Weinheim) 355 (January). Wiley: e2100327–2100327.
  • Dharani, Sathish, Eman M. Mohamed, Tahir Khuroo, Hamed I. Ali, Indra K. Reddy, Ziyaur Rahman, Mansoor A. Khan, and Hamed Alyismail. 2022. “In-Use Stability Assessment of FDA Approved Metformin Immediate Release and Extended-Release Products for N-Nitrosodimethylamine and Dissolution Quality Attributes.” Int J Pharm, January. Elsevier bv, 121923–121923.
  • Gaballah, Mohamed S A, Hamdy E A Ali, Zein A. Hassan, Shahenda Mahgoub, Ham I. Ali, Johng S. Rhim, Mourad Zerfaoui, et al. 2022. “Small Extracellular Vesicle-Associated miR-6068 Promotes Aggressive Phenotypes of Prostate Cancer through miR-6068/HIC2/SIRT1 Axis.” American Journal of Cancer Research 12: 4015–27.
  • Galal, Shadia A., El Diwani, HodaI, Tawfeek H. Abdelhafez, Muhammad K F Khattab, Ahmed Temirak, Yasser M. Shaker, Abu Bakr, SherifaM, et al. 2022. “Design and Synthesis of Antivirals Benzimidazoles and Quinoxalines.” Egyptian Pharmaceutical Journal 21 (January). Medknow: 249–249.
  • Zhang, Jian Kay, Matthew Krivacka Park, Min Hi Meruvu, Catherine Choudhury Sunitha Powell, Mahua, and Mahua Choudhury. 2022. “LncRNA DLEU2 Regulates Sirtuins and Mitochondrial Respiratory Chain Complex IV: A Novel Pathway in Obesity and Offspring’s Health.” Int J Obes (Lond) 46 (January). Springer Science and Business Media LLC: 969–76.
  • Zhang, Jian Powell, Sunitha Sonkar Catherine Meruvu, and Mahua Ravi Choudhury. 2022. “Pyrroloquinoline Quinone Attenuated Benzyl Butyl Phthalate Induced Metabolic Aberration and a Hepatic Metabolomic Analysis.” Biochem Pharmacol 197 (January). Elsevier bv: 114883–114883.
  • Lustig, Robert H., David Collier, Christopher Kassotis, Troy A. Roepke, Min Ji Kim, Etienne Blanc, Robert Barouki, et al. 2022. “Obesity I: Overview and Molecular and Biochemical Mechanisms.” Biochem Pharmacol 199 (January). Elsevier bv: 115012–115012.
  • Heindel, Jerrold J., Sarah Howard, Keren Agay-Shay, Juan P. Arrebola, Karine Audouze, Patrick J. Babin, Robert Barouki, Amita Bansal, Etienne Blanc, Matthew C. Cave, Saurabh Chatterjee, Nicolas Chevalier, Mahua Choudhury, David Collier, Lisa Connolly, Xavier Coumoul, Gabriella Garruti, Michael Gilbertson, Lori A. Hoepner, Alison C. Holloway, George Howell, Christopher D. Kassotis, Mathew K. Kay, Min Ji Kim, Dominique Lagadic-Gossmann, Sophie Langouet, Antoine Legrand, Zhuorui Li, Le Mentec, Helene, Lars Lind, Monica Lind, P, et al. 2022. “Obesity II: Establishing Causal Links between Chemical Exposures and Obesity.” Biochem Pharmacol 199 (January). Elsevier bv: 115015– 115015.
  • Kassotis, Christopher D., Vom Saal, Frederick S, Patrick J. Babin, Dominique Lagadic-Gossmann, Le Mentec, Helene, Bruce Blumberg, Nicole Mohajer, et al. 2022. “Obesity III: Obesogen Assays: Limitations, Strengths, and New Directions.” Biochem Pharmacol 199 (January). Elsevier bv: 115014–115014.
  • Kassotis, Christopher D., Vom Saal, Frederick S, Patrick J. Babin, Dominique Lagadic-Gossmann, Le Mentec, Helene, Bruce Blumberg, Nicole Mohajer, et al. 2022. “Corrigendum to Obesity III: Obesogen Assays: Limitations, Strengths, and New Directions [Biochem. Pharmacol. 199 (2022) 115014].” Biochem Pharmacol 202 (January). Elsevier bv: 115145–115145.
  • Heindel, Jerrold J., Sarah Howard, Keren Agay-Shay, Juan P. Arrebola, Karine Audouze, Patrick J. Babin, Robert Barouki, Amita Bansal, Etienne Blanc, Matthew C. Cave, Saurabh Chatterjee, Nicolas Chevalier, Mahua Choudhury, David Collier, Lisa Connolly, Xavier Coumoul, Gabriella Garruti, Michael Gilbertson, Lori A. Hoepner, Alison C. Holloway, George Howell, Christopher D. Kassotis, Mathew K. Kay, Min Ji Kim, Dominique Lagadic-Gossmann, Sophie Langouet, Antoine Legrand, Zhuorui Li, Le Mentec, Helene, Lars Lind, P Monica Lind, et al. 2022. “Corrigendum to Obesity II: Establishing Causal Links between Chemical Exposures and Obesity [Biochem. Pharmacol. 199 (2022) 115015].” Biochem Pharmacol 202 (January). Elsevier bv: 115144–115144.
  • Shree, Nitya, Zehuan Ding, Jodi Flaws, and Mahua Choudhury. 2022. “Role of microRNA in Endocrine Disruptor-Induced Immunomodulation of Metabolic Health.” Metabolites, January. MDPI, 1034–1034.
  • Bond, Rucha, Karen M S Bastianelli, Simi Gunaseelan, Kevin W. Chamberlin, and Kayce M. Shealy. 2022. “‘How Debate Could Facilitate Group Function in Pharmacy Schools’ Rucha Bond, Karen M.S. Bastianelli, Simi Gunaseelan, Kevin W. Chamberlin, Kayce M. Shealy.”American Journal of Pharmaceutical Education (AJPE), 8864.
  • Buckley, Elizabeth, Simi Gunaseelan, Benjamin D. Aronson, Heidi N. Anksorus, Victoria Belousova, Tram B. Cat, Kristine M. Cline, et al. 2022. “‘Well-Being Content Inclusion in Pharmacy Education Across the US and Canada’ Elizabeth Buckley, Simi Gunaseelan, Benjamin D. Aronson, Heidi N. Anksorus, Victoria Belousova, Tram B. Cat, Kristine M. Cline, Stacey D. Curtis, Christina E. DeRemer, David Fuentes, McKenzie S. Grinalds, Seena L. Haines, Hannah E. Johnson, Karen Kopacek, Jessica M. Louie, Nkem P. Nonyel, Natasha Petry, Shawn Riser Taylor, Suzanne C. Harris, Cheryl A Sadowski, Anandi V. Law.” American Journal of Pharmaceutical Education (AJPE), 8918.
  • Park, Sharon K., Kimberly K K. Daugherty, Srikanth Kolluru, Lisa Lebovitz, Simi Gunaseelan, Beth K. Janetski, Rosalyn P. Vellurattil, and Justine Gortney. 2022. “‘Rethinking the Pharmacy Workforce Crisis by Exploring Unconventional and Emerging Career Pathways and Training’ Sharon K. Park, Kimberly K. Daugherty, Srikanth Kolluru, Lisa Lebovitz,Simi Gunaseelan, Beth K. Janetski, Rosalyn Padiyara Vellurattil, Justine Gortney.”American Journal of Pharmaceutical Education (AJPE) 86: 8773.
  • Mishra, Jayshree, Khyati Amin, Longxiang Kuang, and Narendra Kumar. 2022. “Gut Microbiome and Obesity: Connecting Link.” In , 71–99.
  • Kumar, Premranjan, Jayshree Mishra, and Narendra Kumar. 2022. “Mechanistic Role of Jak3 in Obesity-Associated Cognitive Impairments.” Nutrients 14: 3715–50.
  • Kumar, Narendra, Gianfranco Alpini, and Jayshree. Mishra. 2022. “Role of Jak3 in Cross Talk between Intestinal and Biliary Epithelial Cells.” The FASEB Journal 36.
  • Zhang, Yan, Congqing Wu, Lan Li, Ankit Pandeya, Guoying Zhang, Jian Cui, Daniel Kirchhofer, et al. 2022. “Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death.” Int J Mol Sci 23 (June). MDPI: 6800–6800.
  • Yang, Ling, Ankit Pandeya, Lan Li, Isoiza Ojo, Zhenyu Li, and Yinan Wei. 2022. “Transport Across Two Membrane Bilayers in E. Coli by Efflux Pumps of Different Dimensions.” J Mol Biol 434 (January). Elsevier: 167376–167376.
  • Wei, Yinan, Ling Yang, Ankit Pandeya, Jian Cui, Yan Zhang, and Zhenyu Li. 2022. “Pyroptosis-Induced Inflammation and Tissue Damage.” J Mol Biol 434 (February). Elsevier: 167301–167301.
  • Khuroo, T, E M. Mohamed, Sathish Dharani, S Immadi, Mohammad T. Nutan, Dai Lu, Hamed Alyismail, Mansoor A. Khan, and Ziyaur Rahman. 2022. “In-Situ Implant Formulation of Laurate and Myristate Prodrugs of Dolutegravir for Ultra-Long Delivery.” Journal of Pharmaceutical Sciences111 (August): 2312–21.
  • Dodu, Julien C., Rebecca K. Moncayo, M Imad Damaj, Joel E. Schlosburg, Hamid I. Akbarali, Lesley D. O’Brien, Debra A. Kendall, Zhixing Wu, Dai Lu, and Aron H. Lichtman. 2022. “The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.” J Pharmacol Exp Ther 380 (January). American Society for Pharmacology & Experimental Therapeutics (ASPET): 1–14.
  • Mishra, Jayshree. 2022. “In Utero Exposure to Dietary Emulsifier Alters the Behavioral Activity in Offspring” Volume36, IssueS1 (May). Elsevier (The FASEB Journal).
  • Mishra, Jayshree. 2022. “Role of Jak3 in Cross Talk between Intestinal and Biliary Epithelial Cells” Volume36, (May).
  • Renukuntla, Jwala, Sushesh Srivatsa S. Palakurthi, Pradeep K. Bolla, Br A. Clark, Sai H S Boddu, Prashanth Manda, Samuel Sockwell, Nitin B. Charbe, and Srinath Palakurthi. 2022. “Advances in in-Vitro Bioequivalence Testing Methods for Complex Ophthalmic Generic Products.” International Journal of Pharmaceutics 627: 122209.
  • Palakurthi, Srinath. 2022. “KDM1A Inhibition Augments the Efficacy of Rapamycin for the Treatment of Endometrial Cancer.” Cancer Letters 524 (January). Elsevier BV: 219– 31.
  • Charbe, Nitin Bharat, Murtaza Tambuwala, Sushesh Srivatsa Palakurthi, Amol Warokar, Altijana Hromic-Jahjefendic, Hamid Bakshi, Flavia Zacconi, et al. 2022. “Biomedical Applications of Threedimensional Bioprinted Craniofacial Tissue Engineering.” Bioengineering & Translational Medicine, January. Wiley, -.
  • Renukuntla, Jwala, Sushesh Srivatsa Palakurthi, Pradeep Kumar Bolla, Bradley A. Clark, Sai H S Boddu, Prashanth Manda, Samuel Sockwell, Nitin B. Charbe, and Srinath Palakurthi. 2022. “Advances in in-Vitro Bioequivalence Testing Methods for Complex Ophthalmic Generic Products.” Int J Pharm 627 (January). Elsevier: 122209–122209.
  • Rahman, Ziyaur, Naseem A. Charoo, Mohammad T. Nutan, and Mansoor A. Khan. 2022. “FDA-Approved Novel Dosage Forms.” In Shargel and Yu’s Applied Biopharmaceutics and Pharmacokinetics, Chapter 28. New York, NY: McGraw Hill.
  • Dharani, Sathish, E M. Mohamed, Tahir Khuroo, Ziyaur Rahman, and M A. Khan. 2022. “Formulation Characterization and Pharmacokinetic Evaluation of Amorphous Solid Dispersions of Dasatinib.” Pharmaceutics 14.
  • Khuroo, T, E M. Mohamed, Sathish Dharani, S Immadi, Mohammad T. Nutan, Dai Lu, Hamed Alyismail, Mansoor A. Khan, and Ziyaur Rahman. 2022. “In-Situ Implant Formulation of Laurate and Myristate Prodrugs of Dolutegravir for Ultra-Long Delivery.” Journal of Pharmaceutical Sciences111 (August): 2312–21.
  • Rahman, Ziyaur, Eman M. Mohamed, Sathish Dharani, Tahir Khuroo, Mimy Young, Charles Feng, Todd Cecil, and Mansoor A. Khan. 2022. “Development and Validation Of A Discriminatory Dissolution Method for Portioned Moist Snuff and Snus.” J Pharm Sci 111 (June). Elsevier: 1700–1708.
  • Khuroo, Tahir, Eman M. Mohamed, Sathish Dharani, Canberk Kayalar, Tanil Ozkan, Mathew A. Kuttolamadom, Ziyaur Rahman, and Mansoor A. Khan. 2022. “Very-Rapidly Dissolving Printlets of Isoniazid Manufactured by SLS 3D Printing: In Vitro and In Vivo Characterization.” Mol Pharm 19 (August). American Chemical Society (ACS): 2937–49. Khuroo, Tahir Mohamed, Eman M. Dharani, Sujana Nutan Sathish Immadi, Mohammad T H Lu, Hamed I Khan Dai Ali, Mansoor A. Rahman, Ziyaur, and Ziyaur Rahman. 2022. “In-Situ Implant Formulation of Laurate and Myristate Prodrugs of Dolutegravir for Ultra-Long Delivery.” J Pharm Sci, January. Elsevier bv, 2312–21.
  • Garcia, Caroline R Rad, Armin T. Saeedinejad, Arvind Roy Farnoosh Manojkumar, Hansapani Chew Deepa Rodrigo, Sue Anne Rahman, Mu-Ping Roy Ziyaur Nieh, Upal, and Ziyaur Rahman. 2022. “Effect of Drug-to-Lipid Ratio on Nanodisc-Based Tenofovir Drug Delivery to the Brain for HIV-1 Infection.” Nanomedicine (Lond) 17 (January). Future Medicine Ltd: 959–78.
  • Dharani, Sathish, Eman M. Mohamed, Tahir Khuroo, Hamed I. Ali, Indra K. Reddy, Ziyaur Rahman, and Mansoor A. Khan. 2022. “In-Use Stability Assessment of FDA Approved Metformin Immediate Release and Extended Release Products for N-Nitrosodimethylamine and Dissolution Quality Attributes.” Int J Pharm, January. Elsevier, 121923–121923.
  • Rahman, Mahfoozur, Waleed H. Almalki, Sunil K. Panda, Aman K. Das, Saad Alghamdi, Kriti Soni, Abdul Hafeez, Mayank Handa, Sarwar Beg, and Ziyaur Rahman. 2022. “Therapeutic Application of Microsponges-Based Drug Delivery Systems.” Curr Pharm Des 28 (January). BENTHAM SCIENCE PUBLISHERS: 595–608.
  • Charoo, Naseem Ahmad, Syeed Untoo, and Ziyaur Rahman. 2022. “Using Metabolite Data to Develop Patient Centric Specification for Amide Impurity in Vildagliptin Tablets.” SCIENTIA PHARMACEUTICA 90 (January). MDPI: 1–1.
  • Sundar, Vaishnavi Ramasamy, Mayur Samikkannu Tamizhselvi Doke, and Thangavel. 2022. “Psychostimulants Influence Oxidative Stress and Redox Signatures: The Role of DNA Methylation.” Redox Rep 27 (December). Informa UK Limited: 53–59.
  • Doke, Mayur McLaughlin, Jay P. Cai, James J. Pendyala, Fatah Khan Gurudutt Kashanchi, Mansoor A. Samikkannu, and Thangavel. 2022. “HIV-1 Tat and Cocaine Impact Astrocytic Energy Reservoirs and Epigenetic Regulation by Influencing the LINC01133-Hsa-miR-4726-5p-NDUFA9 Axis.” Mol Ther Nucleic Acids 29 (September). Elsevier bv: 243–58.
  • Doke, Mayur McLaughlin, Jay P. Baniasadi, Thangavel Hamid Samikkannu, and Samikkannu Thangavel. 2022. “Sleep Disorder and Cocaine Abuse Impact Purine and Pyrimidine Nucleotide Metabolic Signatures.” Metabolites 12 (September). MDPI AG: 869–869.
  • Sundar, Vaishnavi McLaughlin, Jay P. Samikkannu, and Thangavel. 2022. “Epigenetic Signature of N-Terminal Acetyltransferases: A Probable Mediator of Immune and Neuropathogenesis in HIV Infection.” Mol Brain 15 (January). Springer Science and Business Media LLC: 69 – .
  • Doke, Mayur Kashanchi, Mansoor A Samikkannu Fatah Khan, and Thangavel. 2022. “HIV-1 Tat and Cocaine Coexposure Impacts piRNAs to Affect Astrocyte Energy Metabolism.” Epigenomics 14 (March). Future Medicine Ltd: 261–78.
  • Zhang, Yan, Congqing Wu, Lan Li, Ankit Pandeya, Guoying Zhang, Jian Cui, Daniel Kirchhofer, et al. 2022. “Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death.” Int J Mol Sci 23 (January). MDPI: 6800–6800.
  • Yang, Ling, Ankit Pandeya, Lan Li, Isoiza Ojo, Zhenyu Li, and Yinan Wei. 2022. “Transport Across Two Membrane Bilayers in E. Coli by Efflux Pumps of Different Dimensions.” J Mol Biol 434 (January). Elsevier: 167376–167376.
  • Wei, Yinan, Ling Yang, Ankit Pandeya, Jian Cui, Yan Zhang, and Zhenyu Li. 2022. “Pyroptosis-Induced Inflammation and Tissue Damage.” J Mol Biol 434 (February). Elsevier: 167301–167301.
  • Mills, Rollie, Ronald J. Vogler, Matthew Bernard, Jacob Concolino, Louis B. Hersh, Yinan Wei, Jeffrey Todd Hastings, Thomas Dziubla, Kevin C. Baldridge, and Dibakar Bhattacharyya. 2022. “Aerosol Capture and Coronavirus Spike Protein Deactivation by Enzyme Functionalized Antiviral Membranes.” Commun Mater 3 (May). Springer Nature: 34 – .
  • Wei, Yinan. 2022. “Abstract 487: Extracellularhistonestrigger Disseminated Intravascular Coagulation By Lytic Cell Death.” Arteriosclerosis Thrombosis and Vascular Biology 42 (May). Wolters Kluwer: a487–a487.
  • Dong, Liangliang, Shen Lin, Lixian Zhong, Dongni Nian, Yiyuan Li, Rixiong Wang, Wei Zhou, Xiuhua Weng, and Xiongwei Xu. 2022. “Evaluation of Tucatinib in HER2-Positive Breast Cancer Patients with Brain Metastases: A United States-Based Cost-Effectiveness Analysis.” Clinical Breast Cancer 22: e21–29.
  • Chen, Yongcong, Lin Wu, Hern ’andez-Mu~noz J. Jose, Miller J. Michael, Melinda Pope, Yidan Huyan, and Lixian Zhong. 2022. “The Economic Burden of Systemic sclerosisâA Systematic Review.” International Journal of Rheumatic Diseases 25: 110–20.
  • Tran, Anh Thu, Elsie Rizk, Eric M. Haas, George Naufal, Lixian Zhong, and Joshua T. Swan. 2022. “Real-World Data on Liposomal Bupivacaine and Inpatient Hospital Costs After Colorectal Surgery.” Journal of Surgical Research 272: 175–83.
  • Chan, Alan, Carolyn Dang, Jessica Wisniewski, Xiuhua Weng, Edward Hynson, Lixian Zhong, and Leslie Wilson. 2022. “A Cost-Effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell Carcinoma.” American Journal of Clinical Oncology 45: 66–73.
  • Ionova, Yelena, Wilson Vuong, Omar Sandoval, Jodie Fong, Vincent Vu, Lixian Zhong, and Leslie Wilson. 2022. “Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USA.” Clinical Drug Investigation 42: 491–500.
  • Li, Yiyuan, Shen Lin, Dong Lin, Lixian Zhong, Yajing Wu, Chen Xie, Shaohong Luo, Xiaoting Huang, Xiongwei Xu, and Xiuhua Weng. 2022. “Disease Burden of Prostate Cancer from 2014 to 2019: Estimation from the Global Burden of Disease Study 2019 and Medical Expenditure Panel Survey.”
  • Lin, Dong, Shaohong Luo, Shen Lin, Lixian Zhong, Wei Zhou, Dian Gu, Xiaoting Huang, Qixin Chen, Xiongwei Xu, and Xiuhua Weng. 2022. “Avelumab Maintenance Treatment After First-Line Chemotherapy in Advanced Urothelial Carcinoma--A Cost-Effectiveness Analysis.” Clinical Genitourinary Cancer.
  • Weng, Xiuhua, Lixian Zhong, Pin Xiang, Yiyuan Li, Alan Paciorek, Liangliang Dong, Jeanette Broering, Peter R. Carroll, Martin Sanda, and Leslie Wilson. 2022. “CostEffectiveness Analysis of Primary Treatments for Localised Prostate Cancer: A Population-Based Markov Analysis Using Real-World Evidence.” European Journal of Cancer Care 31: e13740.
  • Berrios, Kevin, Alexandra Burum, Eunae Jeong, and Lixian Zhong. 2022. “Is Adding Ribociclib to Fulvestrant Cost-Effective in Treating Postmenopausal Women with HR+/HER2-Advanced or Metastatic Breast Cancer? A US Payer Perspective Cost Utility Analysis.” Journal of Managed Care \& Specialty Pharmacy28: 1282–91.
  • Ory, Marcia G., Shinduk Lee, Deborah Vollmer Dahlke, Nicole Pardo, Lixian Zhong, Carly E. McCord, Joy P. Alonzo, Matthew Lee Smith, and others. 2022. “Physiciansâ Interest in Different Strategies for Supporting Pain Management and Opioid Prescribing: A Cross-Sectional Study.” Journal of Opioid Management 18: 511–21.
  • Martin, Leisha M A, Jian Sheng, Paul V. Zimba, Lin Zhu, Oluniyi O O. Fadare, Carol Haley, Meichen Wang, Timothy D. Phillips, Jeremy Conkle, and Wei Xu. 2022. “Testing an Iron Oxide Nanoparticle-Based Method for Magnetic Separation of Nanoplastics and Microplastics from Water.” Nanomaterials (MDPI) 12: 2348
  • Mahmood, Saima, Prapanna Bhattarai, Nauman R. Khan, Zakia Subhan, Ghulam Razaque, H A. Albarqi, Abdulsalam A A. Alqahtani, Ali Alasiri, and Lin Zhu. 2022. “An Investigation for Skin Tissue Regeneration Enhancement/Augmentation by Curcumin-Loaded Self-Emulsifying Drug Delivery System (SEDDS).” Polymers (MDPI) 14.
  • Liu, Yin, Jian Zhang, Ying Tu, and Lin Zhu. 2022. “Potential-Independent Intracellular Drug Delivery and Mitochondrial Targeting.” ACS Nano 16: 1409–20.
  • Balaji Chandrasekaran, Subhasish Tapadar , Bocheng Wu , Uttara Saran , Ashish Tyagi , Alexis Johnston, David A Gaul , Adegboyega K Oyelere , Chendil Damodaran . Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC) (2023). Cancers (Basel) 2023 Vol. 15 Issue 6 .
  • Balaji Chandrasekaran,Ashish Tyagi, Uttara Saran, Venkatesh Kolluru, Becca V Baby, Venkat R Chirasani, Nikolay V Dokholyan, Jyh M Lin, Amandeep Singh, Arun K Sharma, Murali K Ankem and Chendil Damodaran. Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7 (2023). Front Pharmacol. Mar 3; 14:1137783
  • Uttara Saran, Balaji Chandrasekaran, Ashish Tyagi, Vaibhav Shukla, Amandeep Singh, Arun K Sharma and Chendil Damodaran. A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth (2023). Feb 24; 14:1150774.
  • Ashish Tyagi, Balaji Chandrasekaran, Ajit K Navin, Vaibhav Shukla, Becaa V Baby, Murali K Ankem and Chendil Damodaran. Molecular interplay between NOX1 and autophagy in cadmium-induced prostate carcinogenesis (2023). Free Radic Biol Med 2023 Vol. 199, 44-55.
  • Vaibhav Shukla, Balaji Chandrasekaran, Ashish Tyagi, Ajit Kumar Navin, Uttara Saran, Rosalyn M Adam and Chendil Damodaran. A comprehensive transcriptomic analysis of arsenic-induced bladder carcinogenesis (2022). Cells Aug 5;11(15):2435.
  • Amandeep Singh, Asif Raza, Shantu Amin, Chendil Damodaran and Arun K. Sharma. Recent Advances in the Chemistry and Therapeutic Evaluation of Naturally Occurring and Synthetic Withanolides (2022). Molecules. 2022 Jan 28;27(3):886.
  • Horseman M, Panahi L, Udeani G, Tenpas AS, Verduzco Jr R, Patel PH, Bazan DZ, Mora A, Samuel N, Mingle AC, Leon LR. Drug-induced hyperthermia review. Cureus. 2022 Jul 26;14(7).
  • Fontana S, Panahi L, Udeani G, Surani S, Desai D. Case Report Highlighting Cardiovascular Effects of Concomitant Use of Methamphetamine and Marijuana. Cureus. 2022 Aug 10;14(8).
  • Ngo H, Mbadugha UJ, Cepeda F, Surani S, Udeani G. Clinical and Economic Impact of Rapid Blood Pathogen Identification Via Verigene. Cureus. 2022 Oct 16;14(10).
  • Wilks A, Panahi L, Udeani G, Surani S. Review of Gastroesophageal Reflux Pharmacotherapy Management. IntechOpen; 2022. Available from: http://dx.doi.org/10.5772/intechopen.106338.
  • Sadera C, Halliburton S, Panahi L, Udeani G. Introductory Chapter: Pulmonary Embolism. InNew Knowledge about Pulmonary Thromoboembolism 2022 Oct 5. IntechOpen 2022. Available from: http://dx.doi.org/10.5772/intechopen.105018.
  • Ory M, Lee S, Dahlke D, Pardo N, Zhong L, McCord CE, Alonzo J, Smith M. Physicians' interest in different strategies for supporting pain -management and opioid prescribing: A cross-sectional study. J Opioid Manag. 2022 Nov-Dec;18(6):511-521. doi: 10.5055/jom.2022.0746. PMID: 36523202.
  • Ory M, Lee S, Smith M, Alonzo J, Clark H, Burdine J. Differences in the attitudes towards the opioid crisis between metropolitan and rural counties in Central Texas: Secondary data analysis using cross-sectional data. Prev Med Rep. 2022 Mar 8;26:101757. doi: 10.1016/j.pmedr.2022.101757. PMID: 35310324; PMCID: PMC8931431.
  • "Ramirez J., Alarabi A, Khasawneh F, Alshbool F*, “A Novel Antibody Targeting the Second Extracellular Loop of the Serotonin 5-HT2A Receptor Inhibits Platelet Function”, Int J Mol Sci. 2022 Aug 8;23(15):8794."
  • Villalobos-García D, Ali H, Alarabi A.B., El-Halawany M, Alshbool F, and Khasawneh F.T., “Exposure of Mice to Thirdhand Smoke Modulates In Vitro and In Vivo Platelet Responses”, Int J Mol Sci. 2022 May 17;23(10):5595.
  • Alarabi A, Mohsen A, Mizuguchi K, Alshbool F, and Khasawneh F, “Co-expression analysis to identify key modules and hub genes associated with COVID19 in platelets”, BMC Medical Genomics. 2022 Apr 14;15 (1):83.
  • Lozano P, Alarabi A, Garcia S, Boakye E, Kingbong H, Naddour E, Villalobos-García D, Badejo P, El-Halawany M, Khasawneh F, and Alshbool F*, “The Antidepressant Duloxetine Inhibits Platelet Function and Protects against Thrombosis”, Int J Mol Sci. 2022 Feb 26;23(5):2587.
  • Alarabi A, Lozano P, Khasawneh F, and Alshbool F*, “The Effect of Emerging Tobacco Related Products and Their Toxic Constituents on Thrombosis”, Life Sci. 2022 Feb 1;290:120255. doi: 10.1016/j.lfs.2021.120255. Epub 2021 Dec 22.
  • Ali H, Alarabi A, Karim Z, Rodriguez V, Hernandez K Lozano P, El-Halawany M, Alshbool F, and Khasawneh F.T., “In utero thirdhand smoke exposure modulates platelet function in a sex-dependent manner”, Haematologica. 2022 Jan 1;107(1):312-315.
  • Farris C, Diec S, Patel P, Samuel N. Qualitative analysis of third-year pharmacy students’ perceptions about the term “clinical pharmacy”. Am J Pharm Educ. 2022;9026. Doi:10.5688/ajpe9026
  • Jacob J, Halliburton S, Lee J, Ivy D, Farris C. Evaluating changes in second-year pharmacy students study strategies in a pharmacotherapeutics course before and during the coronavirus disease 2019 (COVID-19) pandemic [abstract]. In: Proceedings of Midyear Clinical Meeting for ASHP; 2022 December; Las Vegas, NV.
  • Davis E, Farris C, Roberts M, Ivy D. Evaluation of elective APPE rotations available for fourth-year pharmacy students [abstract]. In: Proceedings of Midyear Clinical Meeting for ASHP; 2022 December; Las Vegas, NV.
  • Boyd T, Alyaseen L, Alyaseen G, Ivy D, Farris C. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with end-stage renal disease on dialysis [abstract]. In: Proceedings of Midyear Clinical Meeting for ASHP; 2022 December; Las Vegas, NV.
  • Dunn K, LaDow T, Farris C. Evaluation of a novel guideline for managing oral factor Xa inhibitor to intravenous unfractionated heparin transitions by utilizing baseline anti-factor Xa levels [abstract]. In: Proceedings of Midyear Clinical Meeting for ASHP; 2022 December; Las Vegas, NV.
  • Hay H, Ivy D, Zolfaghari K. Prescribing patterns and outcomes among patients treated for gestational diabetes mellitus. InBaylor University Medical Center Proceedings 2022 Feb 16 (Vol. 35, No. 2, pp. 172-175). Taylor & Francis.
  • Joshaghani M, Hay H. Perceived Value of Self-Monitoring Blood Glucose (SMBG) by Primary Care Physicians and Endocrinologists. In2020 ACCP VIRTUAL Annual Meeting (October 19-30) 2020 Oct 27. American College of Clinical Pharmacy.
  • Hintze T, Small C, Montgomery J, Reveles K, Hafeez S, Barthol C. Comparison of amantadine, modafinil, and standard of care on promotion of wakefulness following traumatic brain injury. Clin Neuropharmacol. 2022;45(1):1-6.
  • Hintze T, Small C, Montgomery J, Reveles K, Hafeez, S, Barthol C. Amantadine, modafinil, or standard of care for disorders of consciousness after traumatic brain injury. Crit Care Med. 2022;50(1):411.
  • Funderburk D, Weston J, Hintze T. Effect of augmented renal clearance on anti-Xa levels in trauma patients taking enoxaparin. Poster presented at: ASHP Midyear Clinical Meeting; Dec 2022; Las Vegas, Nevada.
  • Varughese K, Weston J, Hintze T. Risk stratification and characterization of acetaminophen overdoses at a community hospital. Poster presented at: ASHP Midyear Clinical Meeting; Dec 2022; Las Vegas, Nevada.
  • Anderson E, Hintze T, Samuel N. Safety outcomes after sacubatril/ valsartan initiation in a community hospital. Poster presented at: ASHP Midyear Clinical Meeting; Dec 2022; Las Vegas, Nevada.
  • Sharma T, Deleon M, Booysen L, Gollhofer B, Dodge D, Samuel N, Hintze T. Maximum dosage of intravenous diltiazem for the treatment of acute atrial fibrillation with rapid ventricular rate. Poster presented at: ASHP Midyear Clinical Meeting; Dec 2022; Las Vegas, Nevada.
  • Sellers J, Jones J, Hintze T. Comparison of 3 dosing strategies of four-factor prothrombin concentrate for warfarin reversal. Poster presented at: TSHP Annual Meeting; May 2022; Round Rock Texas.
  • Davis E, Farris C, Roberts M, Ivy D. Evaluation of elective APPE rotations available for fourth-year pharmacy students [abstract]. In: Proceedings of Midyear Clinical Meeting for ASHP; 2022 December; Las Vegas, NV.
  • Boyd T, Alyaseen L, Alyaseen G, Ivy D, Farris C. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with end-stage renal disease on dialysis [abstract]. In: Proceedings of Midyear Clinical Meeting for ASHP; 2022 December; Las Vegas, NV.
  • Joseph, M, Von Buetter T. Using Design-Based Research Methodology to Improve Two Different Competency-Based Grading Schemas. 2022 ACCP Annual Meeting. San Francisco, CA.
  • Donaldson J, Chowdhury M, Dunlap K, Joseph, M. Student Conceptualizations of Learning in a Covid-19 Survey Study. 2022 Hawai'i International Conference of Education. Hawaii.
  • Chau T, Joseph M, Solomon DM, Lee B, Igneri LA. Heparin Resistance in SARS-CoV-2 Infected Patients with Venous Thromboembolism. Hosp Pharm. 2022 Dec;57(6):737-743. doi: 10.1177/00185787221111743. PMID: 36340634; PMCID: PMC9631007.
  • Zhao Y., Yixun Li A. Choi D. Joseph M, Dunlap K. Students’ perceived support and motivational impact by transition to online learning during COVID-19 pandemic. 2022 AERA Annual Meeting (virtual). https://repository.eduhk.hk/en/publications/students-perceived-support-and-motivational-impact-by-the-transit
  • Patel PH, Ho T, Upadhyay S. A systematic review of warfarin use in post-bariatric surgery patients: Cases compiled for a literature review. Ann Pharmacother. 2022;57(2):193-197.
  • Farris C, Diec S, Patel P, Samuel N. Qualitative analysis of third-year pharmacy students’ perceptions about the term “clinical pharmacy”. Am J Pharm Educ. 2022;9026. Doi:10.5688/ajpe9026
  • Epanya EM, Patel PH, Huon C, Murhammer P, Hamper J. Evaluating prescriber's barriers to utilizing pharmacists in the administration of long-acting injectable antipsychotics in the community setting. Poster presented at: American Pharmacists' Association Annual Meeting. San Antonio, TX. March 18, 2022.
  • Garcia D, Herrera M, Patel PH. The relationship between sleep deprivation and academic performance: It's long-term effect on learning retention. Poster presented at: Texas Society of Health System Pharmacists' Annual Seminar. Round Rock, TX. May 13, 2022.
  • Lee S, Garrison D, Patel PH. How COVID-19 has impacted the different roles of pharmacists across Texas. Poster presented at: Texas Society of Health System Pharmacists' Annual Seminar. Round Rock, TX. May 13, 2022.
  • Nandakisore S, Gutierrez L, Patel PH. A comparison of burnout in pharmacy students with differing levels of prior pharmacy experience. Poster presented at: Texas Society of Health System Pharmacists' Annual Seminar. Round Rock, TX. May 13, 2022.
  • Molina A, Watkins A, Patel PH. Pharmacy directors' attitude on the benefits of infectious disease physician for the development of ASP policies. Poster presented at: Texas Society of Health System Pharmacists' Annual Seminar. Round Rock, TX. May 13, 2022.
  • Aziz AA, Rogers S, Hassanien O, Shalaby L, Nagy M. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation. Personalized Medicine. 2022 Nov;19(6):495-507.
  • Crowder J, Determeyer P, Crowder J, Determeyer P, Rogers S. “Technology is Wonderful Until It Isn't”: Community-Based Research and the Precarity of Digital Infrastructure. InThe Routledge Companion to Media Anthropology 2022 Sep 30 (pp. 77-88). Routledge.. “Technology is Wonderful Until It Isn't”: Community-Based Research and the Precarity of Digital Infrastructure. InThe Routledge Companion to Media Anthropology 2022 Sep 30 (pp. 77-88). Routledge.
  • Patel K, Mukhi H, Patel A, Nathwani N, Mehta D, Sherak J, Clinton N, Pisarik H, Brown B, Rogers S, Kruczynski M. Addressing cancer health disparities in a multilateral collaboration in an independent community cancer clinic: translating words into action. The American Journal of Managed Care. 2022 Aug 1;28(6 Spec No.):SP398-401.
  • Patel K, Mukhi H, Patel A, Mehta D, Clinton N, Brown B, Oh W, Reddy P. Differentiating pseudoprogression from hyperprogression in patients treated with immunotherapies. Targeted Therapies in Oncology. 2022 Feb 14;11(3):16-.
  • Farris C, Diec S, Patel P, Samuel N. Qualitative analysis of third-year pharmacy students’ perceptions about the term “clinical pharmacy”. Am J Pharm Educ. 2022;9026. Doi:10.5688/ajpe9026
  • Thomas A. Li Y, Kaunas C, Newcomb M, Carrino G, Greenwood L, St. Louis P, Marklund L, Samuel N, Chapa H Implementation of a Digital Live-Action Gaming Experience for Interprofessional Learning and Training. In: Dennen, V., Dickson-Deane, C., Ge, X., Ifenthaler, D., Murthy, S., Richardson, J.C. (eds) Global Perspectives on Educational Innovations for Emergency Situations. Educational Communications and Technology: Issues and Innovations. Springer, Cham. 2022. https://doi.org/10.1007/978-3-030-99634-5_20.
  • Braaten B, Samuel N, Hintze T. Correlation of Emergency Severity Index and Medication Reconciliation Discrepancies in a Small Community Teaching Hospital. Poster presented at: TSHP Annual Meeting; May 2022; Round Rock Texas.
  • Stonecipher A, Samuel N, Jones J, Hintze T. Intravenous iron use and protocol development at a community hospital. Poster presented at: TSHP Annual Meeting; May 2022; Round Rock Texas.
  • Galindo A, Bustamante J, Udeani G, Reddy I. Promoting Diversity, Racial Equity, and Inclusive Excellence through a New Initiative at Texas A&M University. Presented at the 123rd Annual Meeting of the American Association of Colleges of Pharmacy, July 23-27, 2022. American Journal of Pharmaceutical Education June 2022, 86 (5) 9172; DOI: https://doi.org/10.5688/ajpe9172.
  • Udeani G, Moore T, Farrell D, Alonzo J, Biggers K, Panahi L, Steinkopf M, Ozmetin J, Flores S, Damodaran C, Han G, Ory M. Pharmacy Advances Clinical Trials (PACT) Network to Achieve Diversity in COVID-19 Clinical Trials: A Strategic Framework. 2023 Texas A&M University – School of Pharmacy Research Colloquium, March 30-31, 2023, College Station, TX.
  • Alba A, Wong R, Farris C. Perioperative anticoagulation bridging trends based on characteristics of patients with atrial fibrillation. Journal of Atrial Fibrillation and Electrophysiology, [In press].
  • Hintze T, Samuel N, Braaten B. A Systematic Review of Escape Room Gaming in Pharmacy Curriculum. Am J Pharm Educ. [In-press]
  • Sellers J, Chang J, Jones J, Hintze T. Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score. J Pulm Pharmacol Therap. 2023;78:102188.
  • Hintze T, Miller JL, Neely SB, Lim SY, Gupta N, Johnson PN. Incidence and characterization of withdrawal in critically-ill children transitioning from fentanyl continuous infusion to methadone in the pediatric intensive care unit. J Opioid Manag. 2023;19(1):43-56.
  • Varughese K, Hintze T, Jones J. Medication use evaluation of alteplase compared to tenecteplase in acute ischemic stroke. Poster presented at: Texas Society of Health-System Pharmacists Annual Meeting; Apr 2023; Galveston, Texas.
  • Anderson E, Hintze T, Jones J. Medication use evaluation of IV push levetiracetam. Poster presented at: Texas Society of Health-System Pharmacists Annual Meeting; Apr 2023; Galveston, Texas.
  • Burum A, Carino J, McBeth M, Samuel N, Hintze T. Review of weight based metoprolol for acute atrial fibrillation with rapid ventricular rate. Poster presented at: Texas A&M University School of Pharmacy Research Colloquium; Mar 2023; College Station, Texas.
  • Funderburk DJ, Hintze T, Jones J. Optimizing levothyroxine dosing for potential organ donors in a community teaching hospital. Poster presented at: Texas A&M University School of Pharmacy Research Colloquium; Mar 2023; College Station, Texas.
  • DiNardo AR, et al. Hutchison, R, Ofili, T, Udeani, G. Bacillus Calmette-Guérin Vaccination as Defense Against SARS-CoV-2 (BADAS): A Randomized Controlled Trial to Protect Health Care Workers in the U.S. by Enhanced Trained Immune Responses. BMC Trials Journal Spr 2023
  • Hutchison, R, Carhart J. Providers in Rural Texas Prescribe Opioid and Benzodiazepine Medication Combination at a Higher Rate. SOP TAMU Research Symposium, Mar 2023
  • Hutchison, R ASPMN: Core Curriculum for Pain Management Nursing, 4e Various book Chapters.
  • Hutchison, R. Opioid and Benzodiazepine Utilization Patterns in Metropolitan and Rural Texas. 54th Annual Conference - Innovations in Addiction Medicine and Science Spr 2023
  • Washington G, Patel PH, Ngo-Chen C, Murhammer P, Hamper J. Assessing patient's comfortability discussing mental health since the beginning of the COVID-19 pandemic in the community pharmacy setting. Poster presented at the American Pharmacists Association (APhA) Annual Meeting. Phoenix, AZ. March 1, 2023.
  • Guzman S, Lao A, Patel PH. The impact of the transition from traditional classes to online/hybrid classes on healthcare student's participation in professional organizations. Poster presented at Texas Society of Health System Pharmacists' (TSHP) Annual Seminar, Galveston, TX. April 21, 2023.
  • Mathews S, Nguyen J, Patel PH. The impact of social media trends on medication use: A study on self-diagnosis and self-prescribing trends. Poster presented at Texas Society of Health System Pharmacists' (TSHP) Annual Seminar, Galveston, TX. April 21, 2023.
  • Amaro J, Martinez S, Patel PH. Impact of sleep on student's emotional wellbeing. Poster presented at Texas Society of Health System Pharmacists' (TSHP) Annual Seminar, Galveston, TX. April 21, 2023.
  • Belbin P, Vargas S, Patel PH. Smartphone addiction and anxiety in pharmacy students. Poster presented at Texas Society of Health System Pharmacists' (TSHP) Annual Seminar, Galveston, TX. April 21, 2023.
  • Oommen A, Payne K, Patel PH. Prevalence in the use of medications for attention deficit/hyperactivity disorder, anxiety, and depression in Texas pharmacy schools. Poster presented at Texas Society of Health System Pharmacists' (TSHP) Annual Seminar, Galveston, TX. April 21, 2023.
  • Washington G, Patel PH, Ngo-Chen C, Murhammer P, Hamper J. Assessing patient's comfortability discussing mental health since the beginning of the COVID-19 pandemic in the community pharmacy setting. Poster presented at the Texas A&M University School of Pharmacy Research Colloquium. College Station, TX. March 2023.
  • Kassam N, Surani S, Hameed K, Aghan E, Mayenga R, Matei I, Jengo G, Bakshi F, Mbithe H, Orwa J, Udeani G. Magnitude, Distribution and Contextual Risk Enhancing Predictors of High 10-Year Cardiovascular Risk Among Diabetic Patients in Tanzania. Patient Related Outcome Measures. 2023 Dec 31:87-96.
  • Xu Q, Jiang M, Gu S, Zhang X, Feng G, MA X, Xu S, Wu E, Huang J, Wang F. Metabolomics changes in brain-gut axis after unpredictable chronic mild stress. Psychopharmacology. Feb 8, 2022.
  • Qin T, Chen K, Li J, Qian W, Xiao Y, Wu E, Ma J, Chen Z, Wang Z, Ma Q, Wu Z. Heat shock factor 1 inhibition sensitizes pancreatic cancer to gemcitabine via the suppression of cancer stem cell-like properties. Biomedicine & Pharmacotherapy. 148:112713. Feb 11, 2022.
  • Zheng Z, Chen Y, Gao L, Meng L, Liu H, Tian H, Wang Y, Feng R, Zhang R, Wang J, Su K, Wu E*, Teng J*, Wang X*, Ding X*. Gut Dysbiosis Influence the Severity of Cryptogenic Stroke by Enhancing Systemic Inflammatory Response. Frontiers in Immunology. May 6, 2022.
  • Duan W, Wang Z, Qian W, Qi D, Ma Q, Wu E*. Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment. Frontiers in Oncology. May 25, 2022.
  • Lu J, Zhang Y, Qi D, Yan C, Wu B, Huang J, Yao J*, Wu E*, Zhang G*. An L-theanine derivative targets against SARS-CoV-2 and its Delta and Omicron variants. Heliyon. June 2022.
  • Pan X, Burgman B, Wu E*, Huang JH*, Sahni N*, Yi SS*. i-Modern: Integrated multi-omics network model identifies potential therapeutic targets in glioma by deep learning with interpretability. Computational and Structural Biotechnology Journal. Volume 20, Pages 3511-3521. June 30, 2022.
  • Chen K, Wang S, Qi D, Ma P, Fang Y, Jiang N, Wu E*, Li N*. Clinical investigations of CAR-T cell therapy for solid tumors. Frontiers in Immunology. July 2022.
  • Fu Y, Chen Y, Tian H, Liu H, Qi D, Wu E*, Wang X*. Identification of BAG5 as a potential biomarker for Parkinson's disease patients with R492X PINK1 mutation. Frontiers in Neuroscience. July 2022.
  • Nizamutdinov D, Ezeudu C, Wu E, Huang JH, Yi SS. Transcranial Near-Infrared Light in Treatment of Neurodegenerative Diseases. Frontiers in Pharmacology. July 2022.
  • Liu Y, Li J, Qu H, Qi D, Hu B, Xu Y, Hu J, Xiong Y, Xia L, Huang JH, Hu X*, Wu E*. Identification of new aptamer BC-3 targeting RPS7 from rapid screening for bladder carcinoma. Genes and Diseases. Aug 3, 2022.
  • Hua X, Y Li, Pentaparthi SR, McGrail DJ, Zou R, Guo L, Shrawat A, Cirillo KM, Li Q, Bhat A, Xu M, Qi D, Singh A, McGrath F, Andrews S, Aung KL, Das J, Zhou Y, Lodi A, Mills GB, Eckhardt SG, Mendillo ML, Tiziani S, Wu E*, Huang JH*, Sahni N*, Y SS*. mGI-map: Landscape of microRNA regulatory network architecture and functional rerouting in cancer. Cancer Research. Oct 20, 2022.
  • Qi D, Li J, Quarles CC, Fonkem E, Wu E*. Assessment and prediction of glioblastoma therapy response: challenges and opportunities. Brain. Nov 29, 2022
  • Qi D, Geng Y, Cardenas J, Gu J, Yi S, Huang JH*, Fonkem E*, Wu E*. Transcriptomic analysis of patient’s peripheral blood with hemoglobin depletion reveals glioblastoma biomarkers. NPJ Genomic Medicine. 8(1):2. Jan 25, 2023.
  • Pan X, Coban Akdemir ZH, Gao R, Jiang X, Sheynkman GM, Wu E*, Sahni N*, Huang JH*, Yi SS*. AD-Syn-Net: Systematic identification of Alzheimer’s disease associated mutation and co-mutation vulnerabilities via deep learning. Briefings in Bioinformatics. Feb 8, 2023.
  • Pan X, Yun J, Coban Akdemir ZH*, Jiang J*, Sahni N*, Wu E*, Huang JH*, Yi SS*. AI-DrugNet: A network-based deep learning model for drug repurposing and combination therapy in neurological disorders. Computational and Structural Biotechnology Journal. Volume 21, 2023, Pages 1533-1542.
  • Wang F*, Wang W, Gu S, Qi D, Smith NA, Peng W, Dong W, Yuan J, Zhao B, Mao Y, Cao P, Lu QR. Shapiro LA, Yi SS, Wu E*, Huang JH*. Distinct astrocytic modulatory roles in sensory transmission during sleep, wakefulness, and arousal states in freely moving mice. Nature Communications. April 17, 2023.
  • Zhou S, Ou H, Wu Y, Qi D, Pei X, Yu X, Hu X*, Wu E*. Targeting tumor endothelial cells with methyltransferase inhibitors: Mechanisms of action and the potential of combination therapy. Pharmacology & Therapeutics. May 10, 2023.
  • Liu Y, Hu B, Li J, Ou H, Qi D, Xu X, Hu J, Xiong Y, Zhou S, Pei X, Jiang B, Huang JH, Wu E*. Hu X*. Discovery of a non-G-quadruplex DNA aptamer targeting NCL for diagnosis and therapy in bladder cancer. Advanced Healthcare Materials. In Press.
  • Qi D*, Ke R, Huang JH, Wu E*. Forging the Future of circRNA Therapeutics: Unleashing Synthetic Potential and Conquering Challenges. Molecular Therapy-Nucleic Acid. In press.
  • Doke M, Kashanchi F, Khan, M.A, Samikkannu T. HIV-1 Tat and Cocaine Impact Astrocytic Energy Reservoir Influence on miRNA Epigenetic Regulation. Genomics, 2021, 113 (6): 3461-3475.  
  • Doke M, Pendyala G, Samikkannu T.  Psychostimulants and Opioids Differentially Influence the Epigenetic Modification of Histone Acetyltransferase and Histone Deacetylase in Astrocytes.  PLoS One 16(6): e0252895. 2021.

  • Sivalingam K, Cirino TJ, McLaughlin JP, Samikkannu T. HIV-Tat and Cocaine Impact Brain Energy Metabolism: Redox Modification and Mitochondrial Biogenesis Influence NRF Transcription-Mediated Neurodegeneration. Mol Neurobiol. 2021.
  • Zhang J, Goel A, Zhu L*, Identification of Novel Alternative Splicing Events Associated With Tumorigenesis, Protein Modification, and Immune Microenvironment in Early-Onset Gastric Cancer, Frontiers in Oncology, 2021, 11, Article 640272.
  • Magne T, Helal-Neto E; Correa L, Alencar L, Gemini-Piperni S, Iram S, Bhattarai P, Zhu L, Ricci-Junior E; Henriques M, Rosas E, Oliveira R, Rheumatoid Arthritis Treatment using Hydroxychloroquine and Methotrexate co-loaded Nanomicelles (127-Pluronic-HCQ-MTX nanomicelles): In vivo results, Colloids and Surfaces B: Biointerfaces, 2021, 206, 111952
  • Kay MK, Zhang J, Choudhury.. Screening for alternative splicing of lncRNA Dleu2 in the mouse liver cell line AML-12. (2021) M.Biomed Rep. Jun;14(6):50.
  • Narendra KumarSalim Surani , George UdeaniSara Mathew , Sharon John , Soniya Sajan , Jayshree Mishra . Drug-induced liver injury and prospect of cytokine-based therapy; A focus on IL-2 based therapies Life Sci. 2021 Aug 1; 278:119544.
  • Hutchison R, Carhart J, Whalen K, Holloway MG. Texas Prescription Drug Monitoring Program Evolution and Outcomes. Texas Journal of Health-System Pharmacy, 2021: 20(2): 22-27.
  • Tenpas AS, Dietrich E. Simplifying medical decision-making for clinical pharmacists. Res Social Adm Pharm. 2021 Jul 31;S1551-7411(21)00284-9.
  • Patel PH. A mom pharmacist working during the pandemic. J Am Pharm Assoc 2021; Published August 21, 2021. Doi: https://doi.org/10.1016/j.japh.2021.08.017.